Low‐Dose Antiangiogenic Therapy With Different Chemotherapy Backbones Among Patients With Heavily Pretreated Metastatic Breast Cancer
Yuanyi Wang, Yalong Qi, Cheng Zeng, Ruixia Song, Yuhan Wei, Haili Qian, Fei Ma · 2026
Read Low‐Dose Antiangiogenic Therapy With Different Chemotherapy Backbones Among Patients With Heavily Pretreated Metastatic Breast Cancer by Yuanyi Wang, Yalong Qi, Cheng Zeng, Ruixia Song, Yuhan Wei, Haili Qian, Fei Ma (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13417479.txt.
Description
Yuanyi Wang and co-authors review records of heavily pretreated metastatic breast cancer patients given vessel blocking therapy plus chemotherapy, in a 2026 multicentre study. Options run thin after many prior treatments. Records for 348 patients were matched into 174 pairs comparing combined treatment with chemotherapy alone.
Matched patients on combined treatment went a median 122 days without progression, versus 90 days on chemotherapy alone. Side effect rates were similar, and most events were mild or moderate. Results varied by which vessel blocking drug and chemotherapy base were used. Dose comparisons were descriptive only, the authors caution, and cannot prove lower doses work as well.
Catalog record
| CREATOR | Yuanyi Wang, Yalong Qi, Cheng Zeng, Ruixia Song, Yuhan Wei, Haili Qian, Fei Ma |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 62 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |